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ABSTRACT.
Purpose: To investigate the association of drusenoid pigment epithelial detachment
(DPED) volume and change in best-corrected visual acuity (BCVA) and central retinal
thickness (CRT) during the growth phase of large DPEDs.
Methods: Patients from an ongoing prospective observational study, the Norwegian
Pigment Epithelial Detachment Study (NORPED), with 1 year of follow-up and DPEDs
≥1000 µm in diameter, examined with the Heidelberg Spectralis HRA-OCTwere included.
Patients with DPEDs in the regression phase were excluded. Multicolour, near-infrared
reflectance, optical coherence tomography (OCT) and OCT angiography images were
obtained every 6 months. Fluorescein angiography and indocyanine green angiography
were performed at baseline and yearly to exclude choroidal neovascularization (CNV).
Results: Forty-four patients and 66 eyes were included. In the statistical model for
BCVA, every 1.0 mm
3
increase in DPED volume led to a decrease in BCVA of 4.0
ETDRS letters (95% CI, 7.0 to 1.0, p = 0.008). A decrease in BCVA was
significantly associated with older patient age, the presence of acquired vitelliform lesions
and subfoveal location of the DPEDs. In the model for CRT, every 1.0 mm3 increase in
DPED volume led to a decrease in CRT of 26.7 µm (95% CI, 44.4 to 9.0,
p = 0.003). Two eyes had progression of geographic atrophy and none developed CNV.
Conclusion: The increasing volume of DPEDs during the growth phase is associated
with a decrease in BCVA and CRT. The subfoveal location of DPEDs and the presence of
acquired vitelliform lesions appear to be associated with a further reduction in BCVA.
Key words: age-related macular degeneration – best-corrected visual acuity – central retinal
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Introduction
Drusen and retinal pigment epithelium
(RPE) abnormalities are the defining
features of age-related macular degen-
eration (AMD) (Bird et al. 1995). The
extent of drusen and RPE abnormali-
ties identified on colour fundus pho-
tography is a known risk factor for
progression to late AMD with chor-
oidal neovascularization (CNV) and
geographic atrophy (Gass 1972; Ferris
et al. 2013; Chew et al. 2014). Druse-
noid pigment epithelial detachment
(DPED) is thought to result from the
confluence of large drusen and in part
by the formation of a hydrophobic
barrier in Bruch’s membrane resulting
in the accumulation of fluid (Casswell
et al. 1985; Roquet et al. 2004). Previ-
ous retrospective studies have observed
that DPEDs could persist, regress with
or without the development of geo-
graphic atrophy, or develop CNV
(Hartnett et al. 1992; Roquet et al.
2004; Alexandre de Amorim Garcia
Filho et al. 2013). Other studies of the
natural history of eyes with DPED
have shown high rates of progression
to geographic atrophy, CNV and
vision loss (Cukras et al. 2010; Yu
et al. 2019). DPEDs are usually located
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in the foveal region and associated with
a loss of best-corrected visual acuity
(BCVA), with or without progression
to central geographic atrophy (Cukras
et al. 2010; Balaratnasingam et al.
2016b; Yu et al. 2019). DPEDs typi-
cally have an initial growth phase
followed by a regression phase with
progressive outer retinal atrophy on
optical coherence tomography (OCT),
ultimately leading to complete RPE
and outer retinal atrophy (cRORA)
(Balaratnasingam et al. 2016b; Sadda
et al. 2018). During the last years,
several risk factors for the progression
of geographic atrophy have been iden-
tified. Drusen disrupt the integrity of
the photoreceptor layer on OCT (Hart-
mann et al. 2012), which has been
shown to be thinner on top of the
drusen (Schuman et al. 2009; Sadigh
et al. 2013). Intraretinal hyperreflective
foci, loss of RPE and outer photore-
ceptor segments, increasing DPED vol-
ume and abnormal DPED thinning on
OCT are associated with progression of
geographic atrophy on colour fundus
photography (Sleiman et al. 2017).
Subretinal drusenoid deposits on OCT
are independent risk factors for loss of
visual function both with and without
associated geographic atrophy and
CNV (Garg et al. 2013).
To our knowledge, the present
study is the first prospective observa-
tional study of DPEDs. In this report,
we have investigated which OCT fea-
tures that could predict a change in
BCVA and central retinal thickness
(CRT) during the growth phase of
DPEDs. We hypothesized, as previ-
ously suggested by Mrejen et al.
(2013), that the larger the DPED
volume the greater the distance from
the RPE to the choriocapillaris, result-
ing in reduced microvascular support
and subsequent progressive outer reti-
nal atrophy with a decrease in BCVA
and CRT.
Material and Methods
This is the first study report on the 1-
year results from an ongoing prospec-
tive, observational, multicentre study,
the Norwegian Pigment Epithelial
Detachment Study (NORPED). The
patients were included from March
2016 to December 2017, and the
planned follow-up period is 5 years.
Ophthalmologists in central and
western Norway referred patients with
DPEDs to the University Hospitals of
Trondheim, Bergen and Stavanger.
The research study was approved by
the Regional Committee for Medical
and Health Research Ethics Central
Norway (2012/1743) and followed the
tenets of the Declaration of Helsinki.
Written informed consent was obtained
from the study participants after expla-
nation of the nature and possible con-
sequences of the study.
Only patients examined with the
Spectralis HRA-OCT (Heidelberg
Engineering GmbH, Heidelberg, Ger-
many) were included in this report.
Other inclusion criteria were age of
≥50 years, DPED with a diameter
≥1000 µm and BCVA ≥20/400. Exclu-
sion criteria were previous vitrectomy,
corticosteroid therapy, intravitreal
anti-vascular endothelial growth factor
injections and photodynamic therapy.
Eyes with subfoveal fibrosis, central
geographic atrophy, CNV on fluores-
cein angiography (FA) or indocyanine
green angiography (ICGA), glaucoma
with central visual field defects, dia-
betic macular oedema, proliferative
diabetic retinopathy and uveitis were
also excluded.
Patients with a pigment epithelial
detachment that appeared yellow on
clinical fundus examination, with pre-
dominantly hyperreflective contents on
OCT, staining on FA and hypofluo-
rescence on ICGA were diagnosed
with DPED (Casswell et al. 1985;
Arnold et al. 1997). Patients with
subretinal fluid and intraretinal cysts
were not excluded if FA and ICGA
did not exhibit features of CNV.
Baseline FA and ICGA images were
pseudonymized and sent to an exter-
nal reading centre to ensure a correct
diagnosis of avascular DPED. Eyes
with leakage on FA and ‘hotspots’ or
‘plaques’ on ICGA were diagnosed
with CNV. Central geographic atro-
phy was defined as a well-demarcated
circular lesion with visible choroidal
vasculature, early hyperfluorescence
on FA and ICGA, and ≥250 µm in
size measured on OCT with foveal
involvement.
Patients were examined by slit-lamp
biomicroscopy and multimodal imag-
ing at baseline, 6 and 12 months. The
multimodal imaging was performed
with the Spectralis HRA-OCT and
consisted of FA, ICGA, near-infrared
reflectance imaging, multicolour imag-
ing, fundus autofluorescence imaging
and OCT. Macular cube scans were
acquired with the follow-up mode, and
a dense scan pattern of 49 scans with
eye-tracking enabled. Each line of the
macular cube scans consisted of 18–30
averaged images recorded with the
automatic real-time function. High
definition line scans centred on the
fovea with 100 averaged images were
also obtained. OCT angiography
(OCTA) was performed at every study
visit with the Cirrus HD-OCT (Carl
Zeiss Meditec AG, Jena, Germany)
(Fig. 1). FA and ICGA were done at
baseline and after 12 months and if
CNV was suspected.
BCVA was measured with an Early
Treatment Diabetic Retinopathy Study
(ETDRS) chart in an illuminated cab-
inet (ESV3000; Good-Lite, Elgin, IL,
USA) at 4 m. The cabinet automati-
cally adjusts lighting to 85 cd/m2.
Room lighting was dimmed so that
100110 Lux could be measured
directly in front of the cabinet. The
refraction was measured at baseline
and yearly by the investigating physi-
cian.
Volumetric measurements of the
DPEDs and intraretinal hyperreflective
foci were done with a semi-automatic
segmentation program (ReV Analyzer
version 3.0.5; ADCIS SA, Saint-Con-
test, France). The DPEDs and
intraretinal hyperreflective foci were in
each OCT scan manually delineated,
which enabled automatic calculation of
their volumes. Intraretinal hyperreflec-
tive foci were defined as hyperreflective
areas in the retina above the ellipsoid
zone on OCT (Fig. 2A). The calliper
available in the viewing software of the
Spectralis HRA-OCT (Spectralis View-
ing Module version 6.0.9.0; Heidelberg
Engineering GmbH, Heidelberg, Ger-
many) was used to measure subfoveal
DPED height, diameter and CRT. The
three centremost scans, centred in the
middle of fovea guided by OCT, were
used for measurements, and the mean
was used for statistical analysis. The
fovea was defined as the innermost
guiding circle (712 µm in diameter) of
the ETDRS grid, available in the
Spectralis Viewing Module, centred in
the middle of the fovea guided by OCT.
The DPEDs were classified as sub-
foveal if their location were within this
circle. CRT was measured from the
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internal limiting membrane to, but not
including, the RPE. Subfoveal thicken-
ing of the RPE, subretinal fluid and
acquired vitelliform lesions were not
included in the measurements. DPED
height was measured from the RPE to
Bruch’s membrane. During measure-
ment, the OCT images were magnified
400800% in the 1:1 µm format.
Subretinal drusenoid deposits
(Fig. 2D) were present if there were
≥5 subretinal deposits in >1 OCT scan
identified on OCT as previously
described by Zweifel et al. (2010).
Acquired vitelliform lesions were
defined as present if there was foveal
subretinal hyperreflective material on
OCT (Fig. 2A). Foveal thickening of
the RPE (Fig. 2B) was defined on OCT
as thickened RPE, with shadowing of
the sub-RPE structures, also visible as
hyperreflective areas on near-infrared
reflectance images.
Grading of atrophy on OCT was
done as described by the Classification
of Atrophy Meeting consensus group
(Sadda et al. 2018; Guymer et al. 2020).
cRORA (Fig. 2D); (1) region of hyper-
transmission of at least 250 µm in
diameter in any lateral dimension, (2)
zone of attenuation or disruption of the
RPE of at least 250 µm in diameter
and (3) evidence of overlying
photoreceptor degeneration. Complete
outer retinal atrophy (cORA)
(Fig. 2C); evidence of photoreceptor
degeneration, but with intact or dis-
continuous RPE. Features of photore-
ceptor degeneration included all of the
following: loss of interdigitation zone,
ellipsoid zone, and external limiting
membrane, and thinning of the outer
nuclear layer, which also could be
identified by a descending outer plexi-
form layer. Incomplete RPE and outer
retinal atrophy (iRORA) (Fig. 2B); the
criteria for cRORA were not met, but
there was hypertransmission <250 µm
in diameter and the RPE-line was
discontinuous with evidence of pho-
toreceptor degeneration.
Statistical analysis
Descriptive statistics and linear mixed
models were used for statistical anal-
ysis. In the linear mixed model, eyes of
patients were nested within patients
with repeated measurements to
account for the correlated eye data
(Ying et al. 2017). Restricted maxi-
mum likelihood estimation was used
for the calculation of fixed effects. R2
statistics were calculated by running
the full models and models including
only DPED volume, diameter and
height with restricted maximum likeli-
hood estimation. The variance of the
fixed effects was calculated after pre-
dicting fitted values based on the fixed
effects alone. As described by Naka-
gawa and Schielzeth, R2 for the fixed
effect(s) and for the full model includ-
ing random effects were calculated and
named R2 marginal and R2 condi-
tional, respectively (Nakagawa &
Schielzeth 2013). The residuals were
visually inspected regarding normal
distribution with histograms and Q–
Q plots. In the building of the statis-
tical models, only observations in the
growth phase of the DPED life cycle
were included. The DPEDs were deter-
mined to be in the regression phase if
the DPED volume decreased and
atrophy progressed after 612 months
of follow-up. Three of 188 observa-
tions were excluded due to the regres-
sion of DPED volume and foveal
cRORA or cORA. Predictors with a
p-value ≥0.05 were excluded from the
statistical models unless the exclusion
worsened model fit. The model fit was
evaluated with Akaike’s information
criterion (Akaike 1974). The primary
statistical models had DPED volume
as the measurement unit of DPED
size. However, secondary analyses of






Fig. 1. Multimodal imaging of a drusenoid pigment epithelial detachment. (A) Multicolour image. (B) Near-infrared reflectance image. (C) Optical
coherence tomography scan. (D) Fundus autofluorescence image. (E) Fluorescein angiography image. (F) Indocyanine green angiography image. (G)
Optical coherence tomography angiography scan. Scale bar = 200 µm.
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were also performed as these parame-
ters were readily available and consid-
ered clinically relevant. STATA 15.1
(StataCorp LLC, College Station,
TX, USA) was used for statistical
analysis.
Results
A total of 66 eyes from 44 patients were
included in the study. Four eyes (6%)
in three patients (7%) were lost to
follow-up. One patient died, another
was diagnosed with dementia, and the
last patient did not want further fol-
low-up. One observation at 6 months
was missing because the OCT image
could not be found in the database. In
two eyes (3%), we observed regression
of the DPED and development of
geographic atrophy, where one pro-
gressed to foveal cORA and the other
to cRORA. There was no foveal
iRORA, cORA or cRORA at baseline.
Three eyes (5%) had extrafoveal
iRORA at baseline, which increased
to six (10%) at 12 months. None of the
eyes developed CNV. Baseline patient
and OCT characteristics are summa-
rized in Tables 1 and 2, respectively.
Best-corrected visual acuity and drusenoid
pigment epithelial detachment volume
In the linear mixed model, each
1.0 mm3 increase in DPED volume
led to a decrease in BCVA of 4.0
ETDRS letters (95% CI, 7.0 to
1.0, p = 0.008) (Fig. 3A), and every
patient-year led to a decrease in BCVA
of 0.4 ETDRS letters (95% CI, 0.6 to
0.2, p < 0.001). The presence of
acquired vitelliform lesions reduced
BCVA by 5.6 ETDRS letters (95%
CI, 8.1 to 3.1, p < 0.001), and
subfoveal location of the DPEDs
Outer plexiform layer
Henle nerve fibre layer

















Disruption of inner segment / outer segment,
external limiting membrane
and evidence of outer retinal atrophy
Attenuation and disruption of 
retinal pigment epithelium 
Hypertransmission
(B)
Incomplete retinal pigment epithelial and outer retinal atrophy (iRORA)
Complete outer retinal atrophy (cORA)
(C)
Loss of interdigitation zone, ellipsoid zone
and external limiting membrane, and thinning of 
the outer nuclear layer
Thickening of retinal pigment 
epithelium
Loss of interdigitation zone, ellipsoid zone
and external limiting membrane, and thinning of 
the outer nuclear layer




Complete retinal pigment epithelial and outer retinal atrophy (cRORA)
(D)
Fig. 2. Pathological findings and classification of atrophy in drusenoid pigment epithelial
detachments on optical coherence tomography scans. (A) Retinal layers, intraretinal hyperreflec-
tive foci and acquired vitelliform lesion. (B) Incomplete retinal pigment epithelial and outer retinal
atrophy (iRORA). (C) Complete outer retinal atrophy (cORA) and thickening of retinal pigment
epithelium. (D) Complete retinal pigment epithelial and outer retinal atrophy (cRORA),
intraretinal cysts and subretinal drusenoid deposits. Scale bar = 200 µm.
Table 1. Baseline patient characteristics
(n = 44 patients).
Range




Metamorphopsia, n (%) 9 (21)
Pseudophakia, n (%) 9 (21)
Female sex, n (%) 33 (75)
Diabetes mellitus, n (%) 2 (5)








BCVA = best-corrected visual acuity,
ETDRS = Early Treatment Diabetic




reduced BCVA by 5.5 ETDRS letters
(95% CI, 10.6 to 0.3, p = 0.036).
Follow-up duration, the presence of
subretinal drusenoid deposits, foveal
subretinal fluid and intraretinal cysts,
and the volume of hyperreflective foci
were not significant predictors of
BCVA. The proportion of the variance
in BCVA predicted by the fixed effects
in the model was 0.40 (R2 marginal)
and by the full model 0.83 (R2 condi-
tional).
Best-corrected visual acuity and foveal
drusenoid pigment epithelial detachment
diameter
In the linear mixed model, each
1000 µm increase in foveal DPED
diameter led to a decrease in BCVA
of 2.1 ETDRS letters (95% CI, 3.5 to
0.6, p = 0.005) (Fig. 3B), and every
patient-year led to a decrease in BCVA
of 0.4 ETDRS letters (95% CI, 0.6 to
0.1, p = 0.003). The presence of
acquired vitelliform lesions reduced
BCVA by 5.6 ETDRS letters (95%
CI, 8.2 to 3.1, p < 0.001), whereas
the presence of subretinal drusenoid
deposits increased BCVA by 3.5
ETDRS letters (95% CI, 0.4 to 6.6,
p = 0.027). Follow-up duration, the
presence of foveal subretinal fluid and
intraretinal cysts, and the volume of
hyperreflective foci were not significant
predictors of BCVA. R2 marginal and
R2 conditional were 0.35 and 0.84,
respectively.
Best-corrected visual acuity and foveal
drusenoid pigment epithelial detachment
height
In the linear mixed model, each
100 µm increase in foveal DPED
height led to a decrease in BCVA of
1.8 ETDRS letters (95% CI, 3.0 to
0.5, p = 0.005) (Fig. 3C), and every
patient-year led to a decrease in BCVA
of 0.3 ETDRS letters (95% CI, 0.6 to
0.1, p = 0.005). The presence of
acquired vitelliform lesions reduced
BCVA by 6.1 ETDRS letters (95%
CI, 8.6 to 3.6, p < 0.001). Follow-
up duration, the presence of subretinal
drusenoid deposits, foveal subretinal
fluid and intraretinal cysts, and the
volume of hyperreflective foci were not
significant predictors of BCVA. R2
marginal and R2 conditional were
0.36 and 0.82, respectively.
Central retinal thickness and drusenoid
pigment epithelial detachment volume
In the linear mixed model, each
1.0 mm3 increase in DPED volume
led to a decrease in CRT of 26.7 µm
(95% CI, 44.4 to 9.0, p = 0.003)
(Fig. 4A). Patient age, subfoveal loca-
tion of the DPEDs, follow-up dura-
tion, the presence of acquired
vitelliform lesions, subretinal druse-
noid deposits, foveal subretinal fluid
and intraretinal cysts, and the volume
of hyperreflective foci were not signif-
icant predictors of CRT. R2 marginal
and R2 conditional were 0.10 and 0.95,
respectively.
Central retinal thickness and foveal
drusenoid pigment epithelial detachment
diameter
In the linear mixed model, each
1000 µm increase in foveal DPED
diameter led to a decrease in CRT of
13.1 µm (95% CI, 19.5 to 6.6,
p < 0.001) (Fig. 4B), and the presence
of subretinal fluid in the fovea led to an
increase in CRT of 8.8 µm (95% CI,
0.4 to 17.3, p = 0.042). Patient age,
subfoveal location of the DPEDs, fol-
low-up duration, the presence of
acquired vitelliform lesions, subretinal
drusenoid deposits and intraretinal
cysts, and the volume of hyperreflective
foci were not significant predictors of
Table 2. Baseline optical coherence tomogra-
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DPED = drusenoid pigment epithelial detach-
ment, HRF = intraretinal hyperreflective foci,
IQR = interquartile range, n = number of
eyes, RPE = retinal pigment epithelium,
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0 100 200 300 400 500
Foveal DPED height [µm](C)
p = 0.008 p = 0.005 p = 0.005
R2m = 0.18 R2m = 0.11 R2m = 0.14
Fig. 3. The associated decrease in best-corrected visual acuity (BCVA) with increasing drusenoid pigment epithelial detachment (DPED) volume,
foveal diameter and height. (A) BCVA and DPED volume. (B) BCVA and foveal DPED diameter. (C) BCVA and foveal DPED height. Statistical
analysis; linear mixed models. The lines represent linear predictions. Scatter plots of BCVA and DPED volume, diameter and height. The marginal
coefficient of determination (R2m) is the proportion of the variance in BCVA predicted by the fixed effects of DPED volume, diameter and height.
N = 185 observations, 66 eyes and 44 patients. A p-value <0.05 was considered statistically significant.
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CRT. R2 marginal and R2 conditional
were 0.08 and 0.95, respectively.
Central retinal thickness and foveal
drusenoid pigment epithelial detachment
height
In the linear mixed model, each
100 µm increase in foveal DPED
height led to a decrease in CRT of
20.2 µm (95% CI, 26.6 to 13.7,
p < 0.001) (Fig. 4C). Patient age, sub-
foveal location of the DPEDs, follow-
up duration, the presence of acquired
vitelliform lesions, subretinal druse-
noid deposits, foveal subretinal fluid
and intraretinal cysts, and the volume
of hyperreflective foci were not signif-
icant predictors of CRT. R2 marginal
and R2 conditional were 0.23 and 0.95,
respectively.
Discussion
This is the first prospective observa-
tional study of DPEDs examined with
multimodal imaging including OCT.
The main findings of this study are
that the increasing volume of DPEDs
during their growth phase is associated
with a reduction in both BCVA and
CRT. Further analysis showed that the
increasing foveal DPED diameter and
height had a similar effect on BCVA
and CRT.
The natural history of large DPEDs
is typically characterized by a growth
phase, followed by a regression
phase leading to geographic atrophy
(Balaratnasingam et al. 2016b). The
observations from our study suggest
that within 1 year, there is progressive
atrophy and a reduction in visual
function in the majority of eyes with
DPEDs during the growth phase.
These findings support the hypothesis
that the RPE function decreases over
time as a consequence of the long-term
separation from the underlying chori-
ocapillaris, leading to RPE atrophy
and photoreceptor loss (Mrejen et al.
2013). In a previous study, it has
also been observed that retinal atro-
phy is associated with DPEDs, as
patients with DPED and poor visual
acuity at baseline had focal foveal
atrophy within the DPED (Roquet
et al. 2004). The association
between decreasing BCVA and increas-
ing DPED volume is in part supported
by the retrospective DPED cohort
studies of the Age-Related Eye Disease
Study (AREDS) Research Group,
where a decline in visual function was
observed in eyes not progressing to late
AMD (Cukras et al. 2010; Yu et al.
2019). In the study by Yu et al., there
was a 26% estimated proportion of
patients without progression to late
AMD who would lose ≥15 ETDRS
letters, and in the study by Cukras
et al., patients not progressing to late
AMD lost eight ETDRS letters over
5 years (Cukras et al. 2010; Yu et al.
2019). These studies used stereoscopic
colour fundus photography to assess
late AMD, and some of the DPEDs
may thus have been in the regression
phase, explaining the vision loss. A
study that used OCT to retrospectively
measure DPED height, diameter and
volume in 21 eyes, found that maxi-
mum DPED size was inversely corre-
lated with final visual acuity. However,
the final visual acuity measurements in
this study were performed during the
regression phase of the DPEDs
(Balaratnasingam et al. 2016b). A
cross-sectional study evaluating macu-
lar function in patients with DPED
found a reduction in visual acuity,
microperimetry sensitivity and multifo-
cal electroretinography responses in
patients with DPEDs compared to
healthy controls (Ogino et al. 2014),
and our results support these findings.
There was an association between
decreasing CRT and increasing DPED
volume, which is plausible as there is a
gradual progression of geographic atro-
phy related to the DPED life cycle.
Previous natural history studies of
DPEDs have not reportedCRT changes
when evaluating the progression of geo-
graphic atrophy.However, a few studies
based on stereoscopic fundus photogra-
phy have shown that the presence of
DPEDs and increasing DPED area are
significant risk factors for the develop-
ment of geographic atrophy (Cukras
et al. 2010; Yu et al. 2019).
The occurrence of acquired vitelli-
form lesions on top of the DPEDs was
in the present study associated with an
additional reduction in BCVA. This
finding is in part supported by a
retrospective study where patients with
both AMD and acquired vitelliform
lesions had a higher risk of foveal
geographic atrophy and a decline in
BCVA compared to those with only
adult-onset foveomacular dystrophy
(Balaratnasingam et al. 2016a). The
vitelliform lesions are thought to arise
from defective phagocytosis of the
RPE, resulting in the accumulation of
outer segment debris and RPE orga-
nelles, and can be considered as a
marker of maximal RPE disturbance
with a focal loss of photoreceptors
(Arnold et al. 2003; Chen et al. 2016;
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Foveal DPED height [µm](A) (B) (C)
p = 0.003 p <0.001 p <0.001
R2m = 0.06 R2m = 0.05 R2m = 0.22
Fig. 4. The associated decrease in central retinal thickness (CRT) with increasing drusenoid pigment epithelial detachment (DPED) volume, foveal
diameter and height. (A) CRT and DPED volume. (B) CRT and foveal DPED diameter. (C) CRT and foveal DPED height. Statistical analysis; linear
mixed models. The lines represent linear predictions. Scatter plots of CRT and DPED volume, diameter and height. The marginal coefficient of
determination (R2m) is the proportion of the variance in CRT predicted by the fixed effects of DPED volume, diameter and height. N = 185
observations, 66 eyes and 44 patients. A p-value <0.05 was considered statistically significant.
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The results of our study suggest that
the subfoveal location of the DPEDs is
unfavourable for visual function. Even
though the majority of DPEDs were
located in the fovea (94%), the few
perifoveal located DPEDs had mark-
edly better BCVA, which demonstrates
the negative impact of DPED volume
on the foveal outer retina.
The presence of intraretinal hyper-
reflective foci is a known risk factor for
the progression to late AMD (Nassisi
et al. 2018). Interestingly, we did not
find that increasing volume of intrareti-
nal hyperreflective foci predicted a
change in BCVA or CRT. On the other
hand, intraretinal hyperreflective foci
are probably a late manifestation of the
disease. The DPEDs in this report have
only 1 year of follow-up, and the
DPEDs in the regression phase were
excluded from the statistical models,
which may explain why we were unable
to document such an association.
DPED is a well-known risk factor
for the development of CNV (Cukras
et al. 2010; Yu et al. 2019). However,
none of our patients developed CNV
during the first year. This may be due
to the relatively short follow-up and
the exclusion of patients with CNV
based on several types of angiography
at baseline.
The strength of this study is its
prospective design, the use of multi-
modal imaging and a low loss to
follow-up. The number of eyes
included was fairly large, considering
the asymptomatic nature of intermedi-
ate AMD and the rarity of large
DPEDs. Only 3% of the patients in
the AREDS study had DPED at base-
line (Cukras et al. 2010). The patients
were also thoroughly investigated with
FA, ICGA and OCTA to exclude
patients with CNV. Subtle type 1
CNV could still have been missed since
11% and 9% of the eyes at baseline
had sub- and intraretinal fluid, respec-
tively. Limitations of the study include
the absence of a control group of AMD
patients without DPED and the lack of
blinding of the study investigator when
measuring the primary outcomes.
Another limitation and future direction
is the possibility to measure the rod-
mediated dark adaptation function.
Rod-mediated vision is affected earlier
and more severely with progression of
AMD, especially in the presence of
subretinal drusenoid deposits (Chen
et al. 2019).
In conclusion, this study has shown
that increasing DPED volume and
foveal DPED diameter and height are
associated with a reduction of BCVA
and CRT during the growth phase of
DPEDs. The subfoveal location of
DPEDs and the presence of acquired
vitelliform lesions appear to be associ-
ated with a further reduction in BCVA.
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